Independent MP Ruth Forrest, who established the inquiry, said there will be three days of initial hearings and then the committee will decide who it will speak to next.
”Key witnesses will be identified, including pharmacists, we need to talk about some of the issues for patients accessing medicinal cannabis,” Ms Forrest said.
”We’re getting research from other countries, the US, some countries in Europe, that have years of experience with medicinal cannabis.
”You can’t completely translate it to Tasmania, but it gives us a good indication of how these things are managed.”
Following on from the inquiry, a report will be presented to Parliament next year, but the committee may also produce an interim report on their findings.
More to come in Saturday’s edition of The Advocate.